Because the Sp1 inhibitor terameprocol dose-dependently reduced cFLIP expression in MM cells (data not shown), caspase-8-mediated degradation of Sp1 can be involved in the reduction of cFLIP expression in MM cells by panobinostat. Here, CFLAR is linked to Miyoshi myopathy.